ABC-1 Activators encompass a diverse array of chemical compounds that enhance the functional activity of ABC-1 through distinct signaling pathways. For instance, Forskolin, by raising intracellular cAMP levels, indirectly enhances ABC-1's functional role by activating PKA, which is known to phosphorylate and activate substrates, including ABC-1. Similarly, PMA, as a potent activator of PKC, leads to phosphorylation events that may enhance ABC-1 activity. The lipid signaling molecule Sphingosine-1-phosphate also contributes to the activation of G-protein-coupled receptors, resulting in signaling cascades that bolster ABC-1's function. Conversely, the kinase inhibitors LY294002 and U0126 suppress specific intracellular signaling pathways (PI3K/Akt and MAPK/ERK, respectively), which can lead to a compensatory enhancement of ABC-1 activity through the release of inhibitory cross-talk or regulatory feedback mechanisms. Additionally, the inhibition of competitive kinase pathways by compounds such as Epigallocatechin gallate (EGCG) and Staurosporine may allow ABC-1 to become more functionally active.
Further enhancing ABC-1's activity are compounds that modulate intracellular calcium levels, such as Ionomycin, Thapsigargin, and A23187 (Calcimycin), each elevating intracellular calcium and activating calcium-dependent signaling pathways that can potentiate ABC-1. Resveratrol, through its activation of the SIRT1 deacetylation pathway, indirectly increases ABC-1's activity by altering the acetylation status of proteins in pathways associated with ABC-1. Finally, SB203580's inhibition of p38 MAPK can shift cellular signaling to favor processes that enhance ABC-1, demonstrating how targeted manipulation of signaling molecules can indirectly augment the functional capacity of ABC-1. Collectively, these activators operate through varied biochemical mechanisms, yet they converge on the common outcome of enhancing ABC-1 activity, underlining the multifaceted nature of cellular signaling and the interconnectivity of pathways that govern protein function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate ABC-1, enhancing its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a kinase inhibitor that can downregulate competitive kinase signaling pathways, indirectly augmenting the functional activity of ABC-1 by reducing inhibitory phosphorylation events. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, activating calcium-dependent proteins and potentially enhancing the activation of ABC-1 through calcium signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in the phosphorylation of many substrate proteins. PKC-mediated phosphorylation can lead to the functional enhancement of ABC-1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, which affects the PI3K/Akt signaling pathway. By inhibiting this pathway, LY294002 can indirectly enhance the activity of ABC-1 by reducing negative feedback or cross-talk that may inhibit ABC-1 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate acts as a bioactive lipid that engages with G-protein-coupled receptors, which may lead to the activation of downstream signaling cascades that enhance ABC-1 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that raises intracellular calcium levels, which can activate calcium-dependent signaling pathways that may enhance ABC-1 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentration, leading to activation of calcium-dependent pathways that can enhance the functional activity of ABC-1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol activates the SIRT1 pathway, which is involved in deacetylation of target proteins. Activation of SIRT1 can indirectly enhance ABC-1 activity through deacetylation-dependent signaling mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, it might shift the signaling equilibrium to favor other pathways, indirectly enhancing the functional activity of ABC-1. | ||||||